AUPN616195A0 - Method and composition for treatment of ocular diseases - Google Patents
Method and composition for treatment of ocular diseasesInfo
- Publication number
- AUPN616195A0 AUPN616195A0 AUPN6161A AUPN616195A AUPN616195A0 AU PN616195 A0 AUPN616195 A0 AU PN616195A0 AU PN6161 A AUPN6161 A AU PN6161A AU PN616195 A AUPN616195 A AU PN616195A AU PN616195 A0 AUPN616195 A0 AU PN616195A0
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- composition
- ocular diseases
- ocular
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000022873 Ocular disease Diseases 0.000 title 1
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPN6161A AUPN616195A0 (en) | 1995-10-23 | 1995-10-23 | Method and composition for treatment of ocular diseases |
EP96934189A EP0859636A4 (en) | 1995-10-23 | 1996-10-22 | Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization |
PCT/AU1996/000664 WO1997015330A1 (en) | 1995-10-23 | 1996-10-22 | Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization |
MYPI96004371A MY134778A (en) | 1995-10-23 | 1996-10-22 | Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization |
CA002235685A CA2235685A1 (en) | 1995-10-23 | 1996-10-22 | Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization |
JP9516137A JP2000507915A (en) | 1995-10-23 | 1996-10-22 | Hyaluronic acid as a DNA carrier for gene therapy and VEGF antisense DNA for treating abnormal retinal neovascularization |
CN96199290A CN1209068A (en) | 1995-10-23 | 1996-10-22 | Hyaluronic acid as DNA carrier for gene therapy and VEGF antisense DNA to treat abnormal retinal vascularization |
KR1019980702900A KR19990066967A (en) | 1995-10-23 | 1996-10-22 | Gene therapy for treating abnormal retinal angiogenesis and hyaluronic acid used as a DNA carrier for VEGF antisense |
NZ320006A NZ320006A (en) | 1995-10-23 | 1996-10-22 | An adjuvant composition comprising hyaluronic acid for gene therapy either in the sense or antisense direction |
AU72664/96A AU721060B2 (en) | 1995-10-23 | 1996-10-22 | Hyaluronic acid as DNA carrier for gene therapy and VEGF antisense DNA to treat abnormal retinal vascularization |
ZA968902A ZA968902B (en) | 1995-10-23 | 1996-10-23 | Methods and compositions for treatment of diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPN6161A AUPN616195A0 (en) | 1995-10-23 | 1995-10-23 | Method and composition for treatment of ocular diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPN616195A0 true AUPN616195A0 (en) | 1995-11-16 |
Family
ID=3790488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPN6161A Abandoned AUPN616195A0 (en) | 1995-10-23 | 1995-10-23 | Method and composition for treatment of ocular diseases |
Country Status (2)
Country | Link |
---|---|
AU (1) | AUPN616195A0 (en) |
ZA (1) | ZA968902B (en) |
-
1995
- 1995-10-23 AU AUPN6161A patent/AUPN616195A0/en not_active Abandoned
-
1996
- 1996-10-23 ZA ZA968902A patent/ZA968902B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA968902B (en) | 1997-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4582797A (en) | Methods for treatment of retinal diseases | |
AU5540594A (en) | Method of performing ophthalmic surgery | |
AU6952896A (en) | Method for treatment of cancer and infectious diseases and compositions useful in same | |
AUPN271295A0 (en) | Method of treatment | |
AU9028798A (en) | Method of improving drug treatment | |
AU2277595A (en) | Device and method for treatment of skin | |
AU5439996A (en) | Compositions and methods for treating pain | |
AU2296995A (en) | Composition and method for treatment of cmv infection | |
AU5960394A (en) | Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases | |
AU3681095A (en) | Method and pharmaceutical composition for prevention and treatment of brain damage | |
AU5605398A (en) | Novel methods and compositions for treatment of autoimmune diseases | |
AU4946699A (en) | Method of treating meniere's disease and corresponding apparatus | |
AU6168296A (en) | Chloroquine analogs and methods of preventing and treating p lasmodial disease | |
AU3607597A (en) | Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases | |
AU5713196A (en) | Method for treatment of pain | |
AU4939296A (en) | Method of reducing prolonged coagulation time | |
AU5699396A (en) | Compositions for the treatment of skin conditions | |
AU4104093A (en) | Method and compositions for treatment of pyonecrotic processes | |
AU6963596A (en) | Method and composition for the manufactue of ophthalmic lenses | |
AU5293293A (en) | Methods and compositions for treatment of allergic disease | |
AUPN115095A0 (en) | Analysis of and compositions and methods for the treatment of disease | |
AUPN616195A0 (en) | Method and composition for treatment of ocular diseases | |
AU7113996A (en) | Methods of treating beta-amyloid-associated conditions | |
AU7985698A (en) | Methods for treatment of ocular neovascularization | |
AU2992295A (en) | Therapeutic method and compounds of use therein |